Prudential Financial Inc. Buys 9,400 Shares of USANA Health Sciences Inc. (USNA)
Prudential Financial Inc. increased its position in shares of USANA Health Sciences Inc. (NYSE:USNA) by 30.0% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 40,717 shares of the company’s stock after buying an additional 9,400 shares during the period. Prudential Financial Inc. owned about 0.33% of USANA Health Sciences worth $4,537,000 as of its most recent SEC filing.
Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Emerald Acquisition Ltd. acquired a new position in shares of USANA Health Sciences during the second quarter worth $4,619,000. Old Mutual Global Investors UK Ltd. raised its position in shares of USANA Health Sciences by 174.8% in the second quarter. Old Mutual Global Investors UK Ltd. now owns 59,105 shares of the company’s stock worth $6,586,000 after buying an additional 37,595 shares in the last quarter. Teachers Advisors Inc. raised its position in shares of USANA Health Sciences by 30.6% in the first quarter. Teachers Advisors Inc. now owns 87,383 shares of the company’s stock worth $10,610,000 after buying an additional 20,496 shares in the last quarter. Barclays PLC raised its position in shares of USANA Health Sciences by 1,181.8% in the first quarter. Barclays PLC now owns 17,432 shares of the company’s stock worth $2,109,000 after buying an additional 16,072 shares in the last quarter. Finally, Societe Generale acquired a new position in shares of USANA Health Sciences during the second quarter worth $1,618,000. 41.86% of the stock is currently owned by institutional investors and hedge funds.
Shares of USANA Health Sciences Inc. (NYSE:USNA) opened at 147.15 on Friday. The firm’s 50-day moving average price is $139.19 and its 200-day moving average price is $127.47. USANA Health Sciences Inc. has a 52-week low of $92.00 and a 52-week high of $150.00. The stock has a market capitalization of $1.77 billion, a P/E ratio of 19.40 and a beta of 1.34.
USANA Health Sciences (NYSE:USNA) last announced its quarterly earnings results on Tuesday, July 26th. The company reported $2.07 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.05 by $0.02. The business had revenue of $258.50 million for the quarter, compared to the consensus estimate of $256.66 million. USANA Health Sciences had a return on equity of 34.15% and a net margin of 10.07%. The business’s revenue was up 10.8% on a year-over-year basis. During the same quarter last year, the business posted $1.92 EPS. Equities analysts forecast that USANA Health Sciences Inc. will post $8.10 earnings per share for the current fiscal year.
A number of brokerages recently weighed in on USNA. Zacks Investment Research lowered USANA Health Sciences from a “strong-buy” rating to a “hold” rating in a report on Wednesday, September 28th. DA Davidson boosted their target price on USANA Health Sciences from $135.00 to $150.00 and gave the stock a “neutral” rating in a research report on Thursday, July 28th. Three investment analysts have rated the stock with a hold rating, one has issued a buy rating and one has assigned a strong buy rating to the stock. The stock currently has a consensus rating of “Buy” and a consensus price target of $149.11.
In related news, Director Gilbert A. Fuller sold 859 shares of the firm’s stock in a transaction that occurred on Monday, August 1st. The stock was sold at an average price of $137.07, for a total value of $117,743.13. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, insider Deborah Woo sold 5,041 shares of the firm’s stock in a transaction that occurred on Thursday, August 18th. The shares were sold at an average price of $131.15, for a total value of $661,127.15. The disclosure for this sale can be found here. 57.00% of the stock is owned by corporate insiders.
USANA Health Sciences Company Profile
USANA Health Sciences, Inc develops and manufactures science-based nutritional and personal care products. It operates as a direct selling company in approximately two geographic regions: Americas and Europe, and Asia Pacific, which includes approximately three sub-regions: Southeast Asia Pacific, Greater China and North Asia.
Want to see what other hedge funds are holding USNA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for USANA Health Sciences Inc. (NYSE:USNA).
Receive News & Ratings for USANA Health Sciences Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for USANA Health Sciences Inc. and related companies with MarketBeat.com's FREE daily email newsletter.